Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill Gilbert

Showing results (31-40 of 78) with videos related to

Pageof 8
Sort By:
International Journal of Radiation Oncology, Biology, Physics|October 17, 2020
Refinement and Validation of the Head and Neck Lymphedema and Fibrosis Symptom InventoryJie Deng, Mary S Dietrich, Kenneth J Niermann, et al.
Integrative Cancer Therapies|June 29, 2018
A Randomized Feasibility Trial to Evaluate Use of the Jaw Dynasplint to Prevent Trismus in Patients With Head and Neck Cancer Receiving Primary or Adjuvant Radiation-Based TherapyLauren A Zatarain, Derek K Smith, Jie Deng, et al.
Head & Neck|December 1, 2011
Vanderbilt Head and Neck Symptom Survey version 2.0: report of the development and initial testing of a subscale for assessment of oral healthEmily Cooperstein, Jill Gilbert, Joel B Epstein, et al.
Oral Oncology|September 6, 2005
The ATM/p53 pathway is commonly targeted for inactivation in squamous cell carcinoma of the head and neck (SCCHN) by multiple molecular mechanismsJennifer Bolt, Quynh N Vo, Wan-Ju Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2012
A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neckJill Gilbert, Michelle A Rudek, Michaela J Higgins, et al.
Cancer|July 19, 2011
Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancerJill Gilbert, Barbara Murphy, Mary S Dietrich, et al.
Head & Neck|July 14, 2012
Impact of secondary lymphedema after head and neck cancer treatment on symptoms, functional status, and quality of lifeJie Deng, Barbara A Murphy, Mary S Dietrich, et al.
Clinical Colorectal Cancer|April 22, 2022
Safety and Efficacy of Avelumab in Small Bowel AdenocarcinomaDana B Cardin, Jill Gilbert, Jennifer G Whisenant, et al.
Journal of Palliative Medicine|May 27, 2016
Internal Lymphedema Correlates with Subjective and Objective Measures of Dysphagia in Head and Neck Cancer PatientsLeanne K Jackson, Sheila H Ridner, Jie Deng, et al.
Critical Reviews in Oncology/Hematology|November 11, 2008
Evolution of clinical trials in head and neck cancerEddy S Yang, Barbara M Murphy, Christine H Chung, et al.
Pageof 8

Showing results (31-40 of 78) with videos related to

Sort By:
Pageof 8
International Journal of Radiation Oncology, Biology, Physics|October 17, 2020
Refinement and Validation of the Head and Neck Lymphedema and Fibrosis Symptom InventoryJie Deng, Mary S Dietrich, Kenneth J Niermann, et al.
Integrative Cancer Therapies|June 29, 2018
A Randomized Feasibility Trial to Evaluate Use of the Jaw Dynasplint to Prevent Trismus in Patients With Head and Neck Cancer Receiving Primary or Adjuvant Radiation-Based TherapyLauren A Zatarain, Derek K Smith, Jie Deng, et al.
Head & Neck|December 1, 2011
Vanderbilt Head and Neck Symptom Survey version 2.0: report of the development and initial testing of a subscale for assessment of oral healthEmily Cooperstein, Jill Gilbert, Joel B Epstein, et al.
Oral Oncology|September 6, 2005
The ATM/p53 pathway is commonly targeted for inactivation in squamous cell carcinoma of the head and neck (SCCHN) by multiple molecular mechanismsJennifer Bolt, Quynh N Vo, Wan-Ju Kim, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 25, 2012
A phase I trial of erlotinib and concurrent chemoradiotherapy for stage III and IV (M0) squamous cell carcinoma of the head and neckJill Gilbert, Michelle A Rudek, Michaela J Higgins, et al.
Cancer|July 19, 2011
Phase 2 trial of oxaliplatin and pemetrexed as an induction regimen in locally advanced head and neck cancerJill Gilbert, Barbara Murphy, Mary S Dietrich, et al.
Head & Neck|July 14, 2012
Impact of secondary lymphedema after head and neck cancer treatment on symptoms, functional status, and quality of lifeJie Deng, Barbara A Murphy, Mary S Dietrich, et al.
Clinical Colorectal Cancer|April 22, 2022
Safety and Efficacy of Avelumab in Small Bowel AdenocarcinomaDana B Cardin, Jill Gilbert, Jennifer G Whisenant, et al.
Journal of Palliative Medicine|May 27, 2016
Internal Lymphedema Correlates with Subjective and Objective Measures of Dysphagia in Head and Neck Cancer PatientsLeanne K Jackson, Sheila H Ridner, Jie Deng, et al.
Critical Reviews in Oncology/Hematology|November 11, 2008
Evolution of clinical trials in head and neck cancerEddy S Yang, Barbara M Murphy, Christine H Chung, et al.
Pageof 8